SOLID BIOSCIENCES INC
Develops gene therapies and therapies in muscle diseases and related conditions.
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying Solid Biosciences' stock with a target price of $16.22, indicating strong growth potential.
Financial Health
Solid Biosciences is generating strong cash flow and has a good book value per share.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring SLDB
Pharma M&A Targets: Biotech Stocks to Watch 2025
AbbVie is spending $2.7 billion on external R&D, highlighting a major industry trend of large pharmaceutical companies acquiring innovation. This creates a potential opportunity among the smaller biotech firms that are becoming prime acquisition targets.
Published: October 5, 2025
Explore BasketGene Therapy's Competitive Shift
The European Medicines Agency's recent rejection of Sarepta Therapeutics' gene therapy creates a potential opening for its competitors. This theme focuses on the biopharmaceutical companies that stand to benefit from this regulatory hurdle in the Duchenne muscular dystrophy market.
Published: July 25, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Gene therapy focus
The company targets the genetic root of Duchenne muscular dystrophy, a high-potential scientific approach — though clinical and safety hurdles can be significant.
Volatility and catalysts
Trial readouts, regulatory updates and financing moves are likely to drive price swings; these events can create both opportunities and sharp downside risks.
Market and funding needs
As a development-stage firm with limited revenues, progression depends on capital, partnerships and regulatory approvals — investors should assess funding plans carefully.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals develops treatments for diseases including cystic fibrosis and cancer.
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals is a leading biotechnology company that develops and manufactures innovative medicines for serious medical conditions.
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing therapeutics based on RNA interference (RNAi).
